Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer

• Main Authors: Ruo-Kai Lin (Author), Chih-Ming Su (Author), Shih-Yun Lin (Author), Le Thi Anh Thu (Author), Phui-Ly Liew (Author), Jian-Yu Chen (Author), Huey-En Tzeng (Author), Yun-Ru Liu (Author), Tzu-Hao Chang (Author), Cheng-Yang Lee (Author), Chin-Sheng Hung (Author)
• Format: Book
• Published: BMC, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Approximately 25% of patients with early-stage breast cancer experience cancer progression throughout the disease course. Alterations in TMEM240 in breast cancer were identified and investigated to monitor treatment response and disease progression. Methods Circulating methylated...